Exploring short-term responses to changes in the control strategy for chlamydia trachomatis (Q428305): Difference between revisions
From MaRDI portal
Set profile property. |
ReferenceBot (talk | contribs) Changed an Item |
||
(One intermediate revision by one other user not shown) | |||
Property / full work available at URL | |||
Property / full work available at URL: https://doi.org/10.1155/2012/803097 / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W2095294742 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q3331035 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Optimal mix of screening and contact tracing for endemic diseases / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: A versatile ODE approximation to a network model for the spread of sexually transmitted diseases / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Monogamous networks and the spread of sexually transmitted diseases / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Contact switching as a control strategy for epidemic outbreaks / rank | |||
Normal rank |
Latest revision as of 08:28, 5 July 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Exploring short-term responses to changes in the control strategy for chlamydia trachomatis |
scientific article |
Statements
Exploring short-term responses to changes in the control strategy for chlamydia trachomatis (English)
0 references
19 June 2012
0 references
Summary: Chlamydia has a significant impact on public health provision in the developed world. Using pair approximation equations we investigate the efficacy of control programmes for chlamydia on short time scales that are relevant to policy makers. We use output from the model to estimate critical measures, namely, prevalence, incidence, and positivity in those screened and their partners. We combine these measures with a costing tool to estimate the economic impact of different public health strategies. Increasing screening coverage significantly increases the annual programme costs whereas an increase in tracing efficiency initially increases annual costs but over time reduces costs below baseline, with tracing accounting for around 10\% of intervention costs. We found that partner positivity is insensitive to changes in prevalence due to screening, remaining at around 33\%. Whether increases occur in screening or tracing levels, the cost per treated infection increases from the baseline because of reduced prevalence.
0 references
0 references